Clinical Trials Logo

Clinical Trial Summary

Is the pain killer consumption after gingival treatment related to the level of patient anxiety or to the type of therapy?


Clinical Trial Description

Anxiety and depression (HAD) scale used could be reveal the level of the patient anxiety and/or depression before intervention. Additionnaly the use of these specific questionnaires (7 items for anxiety, 7 items for depression) could reveal if the pain killer consumption after gingical treatment is dependant to the level of HAD or to the therapy . This tool (HAD) could allows to recognize, before any (oral)surgery, profil with high risk and propose solution to decrease anxiety and/or depression before treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05747092
Study type Interventional
Source University of Liege
Contact leila Salhi, PhD
Phone 0484888091
Email l.salhi@chuliege.be
Status Recruiting
Phase N/A
Start date January 14, 2022
Completion date June 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT04989972 - Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults Phase 2
Completed NCT04925765 - Virtual Reality Biofeedback for Postpartum Anxiety and Depression N/A
Not yet recruiting NCT06188923 - A New Intervention to Improve Function in Veterans With Anxiety and Depression Phase 2
Recruiting NCT06116812 - The Effect of Laughter and Mindfulness Therapy Applications on Women With Breast Cancer Receiving Chemotherapy: Randomized Controlled Study N/A
Completed NCT01197313 - Depression and Quality of Life in Chronic Heart Failure Patients and the Caregivers N/A